Zhejiang Chemsyn Pharm Co (BJSE:920656) Research & Development: ¥10.6 Mil (TTM As of Mar. 2026)


BJSE:920656 Zhejiang Chemsyn Pharm Co Ltd BJSE:920656
36 GF Score
Price ¥14.02
! 4 Warning Signs
View Full Analysis

What is Zhejiang Chemsyn Pharm Co Research & Development?

Zhejiang Chemsyn Pharm Co BJSE:920656 36 Research & Development is ¥10.6 Mil as of Mar. 2026. GuruFocus rates BJSE:920656 with a GF Score™ of 36/100. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Zhejiang Chemsyn Pharm Co's Research & Development for the three months ended in Mar. 2026 was ¥2.7 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥10.6 Mil.

Zhejiang Chemsyn Pharm Co  (BJSE:920656) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Zhejiang Chemsyn Pharm Co Research & Development Related Terms

Zhejiang Chemsyn Pharm Co Research & Development Historical Data

* Premium members only.

The historical data trend for Zhejiang Chemsyn Pharm Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Chemsyn Pharm Co Research & Development Chart

Zhejiang Chemsyn Pharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.04 9.58 9.03 9.58 10.53

Zhejiang Chemsyn Pharm Co Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.69 2.52 2.57 2.75 2.75
BJSE:920656
36GF Score
Zhejiang Chemsyn Pharm Co Ltd BJSE:920656
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Chemsyn Pharm Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥10.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥10.6 Mil mean?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a Research & Development of ¥10.6 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Zhejiang Chemsyn Pharm Co and its competitors.
Is Zhejiang Chemsyn Pharm Co's Research & Development too high?
Zhejiang Chemsyn Pharm Co's current Research & Development is ¥10.6 Mil. Overall, Zhejiang Chemsyn Pharm Co has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Chemsyn Pharm Co's Research & Development compare to UNH and CVS?
Zhejiang Chemsyn Pharm Co's Research & Development of ¥10.6 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Plans company?
A good Research & Development depends on the Healthcare Plans industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. Zhejiang Chemsyn Pharm Co's current Research & Development is ¥10.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Chemsyn Pharm Co stock overvalued right now?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a current Research & Development of ¥10.6 Mil. The current Research & Development is ¥10.6 Mil. Zhejiang Chemsyn Pharm Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Zhejiang Chemsyn Pharm Co (BJSE:920656), the current Research & Development is ¥10.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zhejiang Chemsyn Pharm Co Business Description

Address Huayang Road, No. 36, High-tech Industrial Park, Zhejiang Province, Quzhou, CHN
Zhejiang Chemsyn Pharm Co Ltd is engaged in Research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates.
36GF Score

Get the complete analysis for BJSE:920656

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥14.02
Price